Safety, tolerability and pharmacokinetics (PK) investigation of GSK3494245 in healthy participants

Trial Identifier:	208441
Sponsor:	GlaxoSmithKline
Collaborator:	NA
Start Date:	September 2020
Primary Completion Date:	January 2024
Study Completion Date:	January 2024

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
United Kingdom	Cambridge, United Kingdom, CB2 2GG

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.